Search articles, concepts, and chapters
6 articles in GJC
Grover Davinder S, Kahook Malik Y, Seibold Leonard K, Singh Inder Paul, Ansari Husam, Butler Michelle R et al.
A study of the novel Ahmed ClearPath glaucoma device found it safely and effectively lowered IOP and medication use in refractory glaucoma, offering a new, potentially easier-to-implant treatment option.
Samuelson Thomas W, Singh Inder Paul, Williamson Blake K, Falvey Heather, Katz L Jay, Lee Won Chan et al.
Samuelson Thomas W, Singh Inder Paul, Williamson Blake K, Falvey Heather, Lee Won Chan, Odom Dawn et al.
The iStent inject® pivotal trial found iStent inject® with cataract surgery improved glaucoma patients' quality of life (VFQ-25, OSDI) more than cataract surgery alone, likely by reducing medication dependence.
Ahmed Iqbal Ike K, Rhee Douglas J, Jones Jason, Singh Inder Paul, Radcliffe Nathan, Gazzard Gus et al.
The HORIZON study found Hydrus Microstent combined with cataract surgery safely reduced glaucoma medications and future surgery more effectively than cataract surgery alone for mild-to-moderate POAG.
Falkenberry Suzanne, Singh Inder Paul, Crane Charles J, Haider Mohammed Ali, Morgan Michael G, Grenier Christopher P et al.
This study found excisional goniotomy (KDB) combined with cataract surgery more effectively reduced IOP or medication use than iStent for mild-moderate open-angle glaucoma, with similar safety.
Asrani Sanjay G, Singh Inder Paul
Studying the 3D nature of wedge-shaped RNFL defects and overlying vessel changes improved glaucoma fellows' detection rates, highlighting its clinical utility for early diagnosis.
All 6 articles loaded